Galectin Therapeutics (GALT) Cash & Equivalents Growth (3y) (2013 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -51.77% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | 24.73% |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -28.55% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 13.33% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -16.07% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 21.66% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -8.88% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 36.53% |
| 10 | Galectin Therapeutics | 165.77 Mn | 151.67 Mn | - | -7.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.47% |
| Dec 31, 2025 | -1.59% |
| Sep 30, 2025 | -10.04% |
| Jun 30, 2025 | -17.11% |
| Mar 31, 2025 | -38.28% |
| Sep 30, 2024 | -9.58% |
| Jun 30, 2024 | -6.78% |
| Mar 31, 2024 | 4.30% |
| Dec 31, 2023 | -1.85% |
| Sep 30, 2023 | -14.48% |
| Jun 30, 2023 | -23.90% |
| Mar 31, 2023 | -25.66% |
| Sep 30, 2022 | -32.00% |
| Jun 30, 2022 | -22.55% |
| Mar 31, 2022 | 65.50% |
| Sep 30, 2021 | 53.42% |
| Jun 30, 2021 | 44.39% |
| Mar 31, 2021 | 73.31% |
| Dec 31, 2020 | 107.16% |
| Sep 30, 2020 | 67.26% |
| Jun 30, 2020 | 64.69% |
| Mar 31, 2020 | 46.99% |
| Dec 31, 2019 | 45.66% |
| Sep 30, 2019 | 46.35% |
| Jun 30, 2019 | 42.45% |
| Mar 31, 2019 | -32.19% |
| Dec 31, 2018 | -31.65% |
| Sep 30, 2018 | -21.95% |
| Jun 30, 2018 | -26.43% |
| Mar 31, 2018 | -48.59% |
| Dec 31, 2017 | -52.85% |
| Sep 30, 2017 | -39.36% |
| Jun 30, 2017 | -35.76% |
| Mar 31, 2017 | -28.03% |
| Dec 31, 2016 | 13.56% |
| Sep 30, 2016 | 18.24% |
| Jun 30, 2016 | 52.27% |
| Mar 31, 2016 | 47.14% |
| Dec 31, 2015 | 40.27% |
| Sep 30, 2015 | 24.46% |
| Jun 30, 2015 | 26.16% |
| Mar 31, 2015 | 24.21% |
| Dec 31, 2014 | 65.75% |
| Sep 30, 2014 | 57.78% |
| Jun 30, 2014 | 62.76% |
| Mar 31, 2014 | 73.99% |
| Dec 31, 2013 | 21.20% |
| Sep 30, 2013 | 51.14% |
| Jun 30, 2013 | 21.21% |